Rhumbline Advisers Vertex Pharmaceuticals Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Rhumbline Advisers holds 449,696 shares of VRTX stock, worth $203 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
449,696
Previous 457,905 1.79%
Holding current value
$203 Million
Previous $215 Million 2.56%
% of portfolio
0.19%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$460.0 - $505.78 $3.78 Million - $4.15 Million
-8,209 Reduced 1.79%
449,696 $209 Million
Q2 2024

Aug 01, 2024
SELL
$392.81 - $485.53 $2.09 Million - $2.58 Million
-5,322 Reduced 1.15%
457,905 $215 Million
Q1 2024

May 09, 2024
BUY
$407.69 - $446.08 $1.93 Million - $2.11 Million
4,739 Added 1.03%
463,227 $194 Million
Q4 2023

Feb 08, 2024
SELL
$343.0 - $410.68 $1.81 Million - $2.16 Million
-5,263 Reduced 1.13%
458,488 $187 Million
Q3 2023

Nov 09, 2023
BUY
$338.18 - $362.46 $143,726 - $154,045
425 Added 0.09%
463,751 $161 Million
Q2 2023

Aug 08, 2023
BUY
$314.42 - $351.91 $4.05 Million - $4.54 Million
12,895 Added 2.86%
463,326 $163 Million
Q1 2023

May 11, 2023
BUY
$283.23 - $323.1 $6.71 Million - $7.66 Million
23,694 Added 5.55%
450,431 $142 Million
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $5.3 Million - $5.96 Million
18,554 Added 4.55%
426,737 $123 Million
Q3 2022

Nov 10, 2022
BUY
$273.83 - $305.53 $3.34 Million - $3.72 Million
12,188 Added 3.08%
408,183 $118 Million
Q2 2022

Aug 11, 2022
BUY
$234.96 - $292.55 $3.92 Million - $4.88 Million
16,679 Added 4.4%
395,995 $112 Million
Q1 2022

May 12, 2022
SELL
$221.42 - $260.97 $2.87 Million - $3.38 Million
-12,950 Reduced 3.3%
379,316 $99 Million
Q4 2021

Feb 10, 2022
BUY
$177.01 - $223.45 $1.24 Million - $1.56 Million
6,992 Added 1.81%
392,266 $86.1 Million
Q3 2021

Nov 12, 2021
SELL
$181.39 - $202.99 $2.81 Million - $3.14 Million
-15,482 Reduced 3.86%
385,274 $69.9 Million
Q2 2021

Aug 05, 2021
SELL
$187.49 - $221.1 $19.9 Million - $23.4 Million
-105,890 Reduced 20.9%
400,756 $80.8 Million
Q1 2021

May 06, 2021
SELL
$207.02 - $241.31 $3.23 Million - $3.77 Million
-15,606 Reduced 2.99%
506,646 $109 Million
Q4 2020

Feb 10, 2021
BUY
$207.01 - $276.09 $485,438 - $647,431
2,345 Added 0.45%
522,252 $123 Million
Q3 2020

Nov 12, 2020
SELL
$255.65 - $303.1 $3.24 Million - $3.84 Million
-12,657 Reduced 2.38%
519,907 $141 Million
Q2 2020

Aug 13, 2020
BUY
$225.48 - $295.8 $6.44 Million - $8.45 Million
28,578 Added 5.67%
532,564 $155 Million
Q1 2020

May 06, 2020
BUY
$199.77 - $247.81 $467,661 - $580,123
2,341 Added 0.47%
503,986 $120 Million
Q4 2019

Feb 05, 2020
SELL
$166.71 - $223.91 $1.57 Million - $2.1 Million
-9,394 Reduced 1.84%
501,645 $110 Million
Q3 2019

Oct 23, 2019
BUY
$166.23 - $187.09 $4.07 Million - $4.58 Million
24,490 Added 5.03%
511,039 $86.6 Million
Q2 2019

Aug 14, 2019
BUY
$164.61 - $190.37 $948,812 - $1.1 Million
5,764 Added 1.2%
486,549 $89.2 Million
Q1 2019

May 01, 2019
BUY
$163.73 - $194.7 $4.32 Million - $5.13 Million
26,369 Added 5.8%
480,785 $88.4 Million
Q4 2018

Jan 31, 2019
BUY
$151.91 - $192.21 $974,046 - $1.23 Million
6,412 Added 1.43%
454,416 $75.3 Million
Q3 2018

Nov 07, 2018
SELL
$167.73 - $192.74 $857,603 - $985,479
-5,113 Reduced 1.13%
448,004 $86.3 Million
Q2 2018

Aug 06, 2018
BUY
$145.72 - $169.96 $1.87 Million - $2.18 Million
12,823 Added 2.91%
453,117 $77 Million
Q1 2018

May 02, 2018
SELL
$151.6 - $177.13 $1.16 Million - $1.35 Million
-7,641 Reduced 1.71%
440,294 $71.8 Million
Q4 2017

Feb 09, 2018
BUY
$137.28 - $155.55 $2.81 Million - $3.19 Million
20,478 Added 4.79%
447,935 $67.1 Million
Q3 2017

Nov 06, 2017
BUY
$148.13 - $162.24 $63.3 Million - $69.4 Million
427,457
427,457 $65 Million

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email